newsfilter
← Latest News
GlobeNewswire·

NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results

BELTSVILLE, Md., Nov. 05, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (NASDAQ:NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to